Bharat Biotech cuts vaccine price for States to ₹400/dose
The Hindu
This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
Bharat Biotech on Thursday announced a cut in price of its it plans to sell to the States to . This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.More Related News

Conspiracies hatched to disrupt event linked to 'Babri Masjid' construction in Bengal: Humayun Kabir
TMC MLA Humayun Kabir alleges conspiracies to disrupt a Babri Masjid-style mosque's foundation ceremony in West Bengal amid heightened security.












